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http://www.biomedcentral.com/1471-2253/13/30RESEARCH ARTICLE Open AccessBilateral transversus abdominis plane (TAP) block
with 24 hours ropivacaine infusion via TAP
catheters: A randomized trial in healthy volunteers
Pernille L Petersen1*, Karen L Hilsted1, Jørgen B Dahl1 and Ole Mathiesen2Abstract
Background: The analgesic effect of a TAP block has been investigated in various surgical settings. There are
however limited information about block level and block duration. Furthermore, there is a lack of information about
continuous TAP block after ultrasound-guided posterior TAP blocks.
The aim of this double-blind randomized study was therefore to investigate the effect of an ultrasound-guided
posterior TAP block with 24 hours local anesthetic infusion via a TAP catheter.
Methods: In this randomized study 8 male volunteers received a bilateral TAP block (20 mLs 0.5% ropivacaine) and
were allocated to receive active infusion (ropivacaine 0.2% 5 mL/hr) via a TAP catheter on one side and placebo
infusion on the other side. Primary outcome: Dermatomal sensory block involvement after 24 hours evaluated with
pinprick. Secondary outcomes: Sensory block involvement evaluated with cold test and heat-pain detection
thresholds (HPDT) on the abdominal wall. Assessment points: 15 min before block performance and 1, 4, 8, 12 and
24 hours after block performance.
Results: The TAP block primarily involved sensory changes in the Th10 to Th12 dermatomes. On the placebo side
there was a decrease in extension beginning at 4–8 hours after block performance and with no detectable effect
beyond 12 hours. Median number of dermatomes anesthetized (pinprick) at 24 hours after block performance was
1.5 (0–3) on the active side compared with 0 (0–0) on the placebo side (P = 0.039).
There were no statistical significant between-side differences in HPDT measurements at 24 hours after
block performance.
Conclusions: The spread of sensory block following ultrasound-guided posterior TAP block is partly
maintained by a continuous 24 hour ropivacaine infusion through a TAP catheter.
Trial registration: The study was registered at NCT01577940
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Transversus abdominis plane (TAP) block is a regional
anesthetic technique that blocks neural afferents of the an-
terolateral abdominal wall. Nerves located within the TAP
are the intercostal, subcostal and ilioinguinal/iliohypogastric
nerves (T6-L1).
The analgesic effect of a TAP block has been investi-
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reproduction in any medium, provided the orlimited information about block level and block duration.
Furthermore, there is a lack of information about con-
tinuous TAP block after ultrasound-guided posterior
TAP blocks [1]. Continuous peripheral nerve blocks pro-
vide superior postoperative analgesia when compared with
opioid analgesia [2]. Hebbard et al. described a technique
for continuous oblique subcostal TAP block, where in-
fusion with ropivacaine 0.2% 5 mL/hr via subcostal TAP
catheters was used [3].
The aim of this double-blind randomized study was to
investigate the effect of an ultrasound- guided posterior
TAP block with 24 hours local anesthetic infusion via al Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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sory block involvement after 24 hours evaluated with
pinprick. Secondary endpoints were dermatomal sensory
block involvement evaluated with cold test and sensory
block evaluation with Heat Pain Detection Threshold
(HPDT) measurements.
Methods
The study was carried out at Rigshospitalet, Copenhagen,
Denmark. Approval was obtained from the Regional Ethics
Committee, the Danish Medicine Agency, and the Danish
Data Protection Agency. The study was conducted in com-
pliance with guidelines for Good Clinical Practice (GCP)
and was monitored by The Copenhagen University Hospital
GCP unit. Furthermore, the design and the description of
the study are in accordance with the Consolidated Standards
of Reporting Clinical Trials (CONSORT) [4]. The study
was registered at www.clinicaltrials.gov in December 2011.
Participants
Male volunteers (18–30 years) with American Society of
Anesthesiology performance status 1 were included in
the study. Exclusion criteria were as follows: BMI below
18 or above 25 kg/m2, inability to understand Danish,
relevant drug allergy, alcohol or drug abuse, a daily in-
take of prescription pain medication for the last 4 weeks,
consumption of pain medications within 48 hours before
study inclusion and previous abdominal operations.
The volunteers received both written and oral infor-
mation regarding the trial. Signed informed consent was
obtained from all volunteers.
Interventions, blinding and randomization
This was a randomized, double-blinded and placebo
controlled study. An US-guided TAP block was performed
bilaterally in all volunteers by one investigator (PLP). An
ultrasound probe (GE Health care, Venue 40) was placed
transversely in the midaxillary line between the iliac crest
and the costal margin at the level of the umbilicus. The
external oblique, internal oblique and transversus ab-
dominis muscles and their fascia were visualized. An
18-gauge 100 mm needle (Contiplex S ultraset, B. Braun
Medical A/S) was introduced anteriorly and in the plane
of the US-probe. Following negative aspiration, 20 mL
of ropivacaine 0.5% was injected into the TAP and the
injectate was seen spreading in the transversus abdominis
plane as a dark oval shape. A TAP-catheter was placed in
the TAP fascial space after bolus injection. An infusion
pump (Coopdech Syrinjector, Daiken Medical) with 120
mL of study solution was connected to the TAP catheter
and a volume of 5 mL/hour was infused via the catheter.
The volunteers were randomly assigned to one of 2
groups. Group 1: Ropivacaine 0.2% in the TAP catheter
on the left side and saline in the catheter on the rightside. Group 2: Ropivacaine 0.2% in the TAP catheter
on the right side and saline on the left side. Study
medication was prepared by the hospital pharmacy into
identical boxes containing identical ampoules of either
6 × 20 mL of isotonic saline or 6 × 20 mL of 0.2%
ropivacaine, with two boxes for each patient marked left
and right. The boxes were sealed and marked with the
name of the project, the investigators name, and con-
secutive numbers according to a computer-generated
block randomization list prepared by the hospital phar-
macy. The volunteers and the investigators were blinded
to group assignments. The investigators (PLP, KLH)
performed all assessments. The volunteers stayed in hos-
pital for 24 hours followed by a phone call at home after
48 hours.Outcomes
The participants were assessed 15 minutes before block
performance and at 1, 4, 8, 12 and 24 hours after TAP
block performance.
The primary outcome measure of the study was differ-
ence in extend of sensory block at 24 hours post block
between groups estimated with pinprick on the abdom-
inal skin 5 cm lateral of the midline.
The secondary outcomes measures were spread and ex-
tend of sensory block estimated with cold test and Heat
Pain Detection Threshold (HPDT) on the abdominal wall
bilaterally.
HPDT represents the lowest temperature that is per-
ceived as painful. A thermode (12.5 cm2, Thermotest,
Somedic A/B, Hörby, Sweden) was placed on normal skin
of the abdominal wall, 5 cm below the umbilicus and
5 cm lateral to the midline bilaterally. The starting
temperature of the thermode was 32°C, and the rate of in-
crease was 1°C/s. By pressing a button, subjects indicated
when the threshold was reached. If the cutoff limit (52°C)
was reached before the pertinent threshold, the thermode
returned automatically to the starting value, and 52°C was
registered. Each threshold was calculated as an average
of four stimulations; stimulations were 6–10 s apart.Sample size
We were not able to find any study that demonstrated
the sensory spread after 24-hour infusion via TAP cathe-
ters. In a previous study the mean sensory extend of a
bilateral TAP block with 2 × 20 mL of ropivacaine were
6 dermatomes (SD 1.7) for pinprick evaluated 30 minutes
after block performance [5]. Based on the sensory spread
at 30 minutes after block performance, we thought that a
difference of 30% of dermatomes involved (= 2 derma-
tomes) between the active and the placebo infusion side
after 24 hours infusion via TAP catheters was estimated to
be of clinical relevance. With a Type 1 error of 0.05 and a
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that 8 volunteers were needed in the study.
Statistical methods
Statistical analyses were performed using SPSS 19 (SPSS,
Chicago, Illinois, USA). Data are presented as median
and range (minimum-maximum). The Wilcoxon signed
rank test was used to test for differences between groups
at 24 hours post-block. The investigators did all statis-
tical analyses.
P< 0.05 was considered as level of significance.
Results
Eight volunteers were approached for participation in the
study in January 2012. All 8 were recruited and randomly
assigned to their treatment group. Baseline characteristics
were as follows: Median age 23 years (20–26), height
180 cm (177–198) and weight 80 kg (71–93).
A total of 16 TAP blocks and TAP catheters were
performed. All blocks were performed by one investiga-
tor (PLP) as described in the methods section. Three out
of the 16 catheters were displaced between 12 and 24 hours
after block performance and 1 block failed to produce any
sensory block at all time points assessed. Results from all
16 infusions were included in the final intention-to-treat
analysis (Figure 1).
We suspected a toxic reaction of ropivacaine in one
participant 1 hour after block performance. However,
complete recovery was achieved within 1 hour afterAssessed for eli
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Figure 1 Flow diagram over volunteer distribution. Flow diagram overinfusion of 2000 mL of Ringers lactate. This volunteer
was not assessed at 1 hour post block but data from all
other time-points are included.Primary outcome
The mean number of dermatomes anesthetized at 24 hours
post block evaluated with pinprick was 1.5 (0–3) on the
active side compared with 0 (0–0) on the placebo side
(P = 0.039).
The median upper and lower dermatome involvement
is presented in Table 1.Secondary outcomes
Extend of sensory block estimated with cold test
The mean number of dermatomes anesthetized at 24
hours evaluated with cold test were 2 (0–3) on the active
side and 0 (0–0) on the placebo side (P=0.034).Sensory block estimated with heat pain detection
threshold (HPDT)
Levels of HPDT (abdomen) scores were not significantly
different between groups at 24 hours. HPDT score at each
time point assessed are presented in Figure 2. The figure
shows a maximum effect of the TAP block at 4h after
block performance which is partly maintained on the
active side at 24 hours and ceased on the placebo side.gibility (n=8) 
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volunteer inclusion, randomization and interventions.
Table 1 Dermatomes involved in TAP blockade
Active Placebo
Number of dermatomes involved at 24 h
Pin Prick 1.5 (0–3) 0 (0–0) P=0.039
Heat/Cold 2.0 (0–3) 0 (0–0) P=0.034
Upper and lower dermatomal involvement (Pin Prick)
1h T10 to T12 T10 to T12
4h T10 to T11 T10 to T12
8h T11 to T12 T11 to T12
12h T10 to T12 None
24h T10 to T11 None
Upper and lower dermatomal involvement (cold test)
1h T10 to T12 T10 to T12
4h T10 to T12 T10 to T12
8h T11 to T12 T10 to T12
12h T11 to T12 None
24h T10 to T11 None
Median and (minimum-maximum).
Sensory spread after TAP block and infusion via TAP catheters. Active indicates
infusion with ropivacaine and placebo with saline in the TAP catheters. The hours
indicate time from TAP block performance.
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This randomized controlled trial showed that both a pin-
prick and a cold test sensory block produced with a TAP
block can be maintained with an infusion of local anes-
thetics via a TAP catheter. We have demonstrated a sig-
nificant difference between placebo and active infusion
for our primary endpoint, dermatomal involvement at
24 hours after TAP block performance. Furthermore, weFigure 2 Heat pain detection threshold (HPDT). HPDT represents the lo
conducted on abdominal skin bilaterally before block performance and 1, 4believe that the differences in HPDT scores between the
two groups supports this primary result, although these
scores failed to display significance at 24 hours after
block performance. Due to the limited sensory spread of
the TAP block, the thermode that was used for the HPDT
measurements was unavoidably placed partly on non anes-
thetized skin which may have interfered with assessments.
The TAP block primarily involved sensory changes in
the Th10 to Th12 dermatomes. On the placebo side there
was a decrease in extension beginning at 4–8 hours post
block and with no detectable effect beyond 12 hours. In
another recent study with healthy volunteers the dermato-
mal involvement after posterior TAP blockade was com-
parable to our study [6]. However; in this study 30 mL of
ropivacaine 0.375% was used for the block. In a different
study Lee et al. [7] demonstrated a primary TAP block
involvement of Th10 to Th12 in patients undergoing
different types of abdominal surgery, but also found in-
volvement of T9 in 30% and L1 in 50% of the TAP blocks
which even lasted for up to 24 hours in some cases.
Finally, Mitchell et al. [5] demonstrated a sensory derma-
tomal involvement of primarily Th10 –Th12 in a group
of abdominal surgery patients. These patients all received
a posterior TAP block (2 × 20 mL of ropivacaine 0.5%)
preoperatively and were tested for spread for the following
30 minutes. Collectively, data indicate that in both pa-
tients and volunteers, an ultrasound guided posterior
TAP block only produces a limited sensory block.
In this study we suspected a toxic reaction to local
anesthetic 1 hour after TAP block performance in one
participant. Three studies have demonstrated a risk of sys-
temic toxicity of local anesthetic as a result of absorptionwest temperature that is perceived as painful. Measurements were
, 8, 12 and 24 hours after block performance.
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both lidocaine and ropivacaine [8-10]. These studies found
a mean peak plasma concentration 30 minutes after block
performance. Griffiths found a level of plasma ropivacaine
over the toxic level that was maintained for several hours
in some patients [9]. A recent study demonstrated reduced
peak plasma concentrations of local anesthetics after
unilateral TAP block when epinephrine was added to
the solution [11]. Absorption of the local anesthetic into
the circulation depends primarily on the vascularity of the
site of deposition [12]. As the TAP is well vascularised and
the area of absorption rather large it can explain the
high peak plasma concentrations of local anesthetics in
this type of block.
There are some limitations to our study. Three of sixteen
catheters were displaced from 12 to 24 hours and we
experienced one block failure. Niraj et al. studied the
analgesic effect of subcostal transversus abdominis plane
catheters versus epidural catheters, and in that study 45%
of TAP catheters had to be re-sited within the first
24 hours after surgery [13]. In a study of pulmonary
function in healthy volunteers that had bilateral TAP
blockade, 2 out of 11 volunteers had bilateral block failure
[14]. We should have anticipated problems with block
failure and catheter displacements and taken this into
account in our sample size calculation. However, we
found a statistically significant difference in our primary
outcome despite of block failures and catheter displace-
ment. Another limitation is that the study was conducted
on healthy volunteers, the insertion of TAP catheters
and their likely success is more problematic in a surgical
population.
Conclusions
This study demonstrates that an ultrasound-guided pos-
terior TAP block produces a limited sensory spread with
primary involvement of Th10-Th12 in healthy male volun-
teers. Furthermore, the spread of sensory block are partly
maintained by a continuous 24 hour ropivacaine infusion
via a TAP catheter.
Competing interests
The authors declare no competing interests.
Authors’ contributions
PLP, JBD and OM designed the experiments. PLP and KLH collected the data.
PLP, JBD and OM analysed the data and drafted the manuscript. All authors
read and approved the final manuscript.
Sources of funding
The study was funded by the Departments of anaesthesia Copenhagen
university hospital, Glostrup and Rigshospitalet and by the “Familien Hede
Nielsens foundation”, which paid the salary for the volunteers.
Author details
1Department of Anesthesia, Centre of Head and Orthopedics, Copenhagen
University Hospital, Rigshospitalet, Copenhagen, Denmark. 2Section of AcutePain Management, Copenhagen University Hospital, Rigshospitalet,
Copenhagen, Denmark.
Received: 30 May 2013 Accepted: 7 October 2013
Published: 10 October 2013
References
1. Abdallah FW, Chan VW, Brull R: Transversus abdominis plane block:
a systematic review. Reg Anesth Pain Med 2012, 37:193–209.
2. Richman JM, Liu SS, Courpas G, Wong R, Rowlingson AJ, McGready J, et al:
Does continuous peripheral nerve block provide superior pain control to
opioids? a meta-analysis. Anesth Analg 2006, 102:248–257.
3. Hebbard PD, Barrington MJ, Vasey C: Ultrasound-guided continuous
oblique subcostal transversus abdominis plane blockade: description of
anatomy and clinical technique. Reg Anesth Pain Med 2010, 35:436–441.
4. Schulz KF, Altman DG, Moher D: CONSORT 2010 statement: updated
guidelines for reporting parallel group randomised trials. Int J Surg 2011,
9:672–677.
5. Mitchell AU, Torup H, Hansen EG, Petersen PL, Mathiesen O, Dahl JB, et al:
Effective dermatomal blockade after subcostal transversus abdominis
plane block. Dan Med J 2012, 59:A4404.
6. Borglum J, Jensen K, Christensen AF, Hoegberg LC, Johansen SS, Lonnqvist
PA, et al: Distribution patterns, dermatomal anesthesia, and ropivacaine
serum concentrations after bilateral dual transversus abdominis plane
block. Reg Anesth Pain Med 2012, 37:294–301.
7. Lee TH, Barrington MJ, Tran TM, Wong D, Hebbard PD: Comparison of
extent of sensory block following posterior and subcostal approaches to
ultrasound-guided transversus abdominis plane block. Anaesth Intensive
Care 2010, 38:452–460.
8. Torup H, Mitchell AU, Breindahl T, Hansen EG, Rosenberg J, Moller AM:
Potentially toxic concentrations in blood of total ropivacaine after
bilateral transversus abdominis plane blocks; a pharmacokinetic study.
Eur J Anaesthesiol 2012, 29:235–238.
9. Griffiths JD, Barron FA, Grant S, Bjorksten AR, Hebbard P, Royse CF: Plasma
ropivacaine concentrations after ultrasound-guided transversus
abdominis plane block. Br J Anaesth 2010, 105:853–856.
10. Kato N, Fujiwara Y, Harato M, Kurokawa S, Shibata Y, Harada J, et al: Serum
concentration of lidocaine after transversus abdominis plane block.
J Anesth 2009, 23:298–300.
11. Corvetto MA, Echevarria GC, De La Fuente N, Mosqueira L, Solari S,
Altermatt FR: Comparison of plasma concentrations of levobupivacaine
with and without epinephrine for transversus abdominis plane block.
Reg Anesth Pain Med 2012, 37:633–537.
12. Rosenberg PH, Veering BT, Urmey WF: Maximum recommended doses of
local anesthetics: a multifactorial concept. Reg Anesth Pain Med 2004,
29:564–575.
13. Niraj G, Kelkar A, Jeyapalan I, Graff-Baker P, Williams O, Darbar A, et al:
Comparison of analgesic efficacy of subcostal transversus abdominis
plane blocks with epidural analgesia following upper abdominal surgery.
Anaesthesia 2011, 66:465–471.
14. Petersen M, Elers J, Borglum J, Belhage B, Mortensen J, Maschmann C: Is
pulmonary function affected by bilateral dual transversus abdominis plane
block? a randomized, placebo-controlled, double-blind, crossover pilot
study in healthy male volunteers. Reg Anesth Pain Med 2011, 36:568–571.
doi:10.1186/1471-2253-13-30
Cite this article as: Petersen et al.: Bilateral transversus abdominis plane
(TAP) block with 24 hours ropivacaine infusion via TAP catheters: A
randomized trial in healthy volunteers. BMC Anesthesiology 2013 13:30.
